AMYLIN PHARMACEUTICALS INC·4

Jun 2, 10:56 AM ET

AMYLIN PHARMACEUTICALS INC 4

4 · AMYLIN PHARMACEUTICALS INC · Filed Jun 2, 2006

Insider Transaction Report

Form 4
Period: 2006-06-01
Transactions
  • Exercise/Conversion

    Common Stock

    2006-06-01$18.85/sh+1,500$28,27523,293 total
  • Sale

    Common Stock

    2006-06-01$45.59/sh1,500$68,38521,793 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2006-06-011,50017,800 total
    Exercise: $18.85From: 2003-05-12Exp: 2013-05-12Common Stock (1,500 underlying)
  • Sale

    Common Stock

    2006-06-01$46.64/sh500$23,32021,793 total
  • Exercise/Conversion

    Common Stock

    2006-06-01$18.85/sh+500$9,42522,293 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2006-06-0150017,300 total
    Exercise: $18.85From: 2003-05-12Exp: 2013-05-12Common Stock (500 underlying)
Footnotes (1)
  • [F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT